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ABSTRAK 
WIJFFELS, GENE., TONY VUOCOLO, SRI MUHARSINI, dan FLORENTINA SUPRIYANTI. 2000. Ekspresi bakterial dari peritrofin larva 
Chrysomya bezziana. Jurnal Ilmu Ternak dan Veteriner (Edisi Khusus) 5 (3): 170-176. 
Tiga antigen kandidat lalat Chrysomya bezziana, Cb-peritrofin-48, -15, dan -42 disiapkan untuk produksi protein 
rekombinan pada Escherichia coli dengan menggunakan berbagai vektor ekspresi. Cb48 telah berhasil diekspresikan sebagai 
protein rekombinan yang mempunyai sebuah terminal-karboksi dengan label hexaHis. Cb15 diekspresikan baik sebagai fusi 
protein S-transferase glutation maupun sebagai protein yang berlabel hexaHis pada terminal-amino. Konstruksi S-tranferase 
glutation Cb15 menghasilkan sebuah grup fusi protein yang heterogen. Cb42 juga diekspresikan sebagai protein yang berlabel 
hexaHis pada terminal-amino. Kultur protein yang berlabel hexaHis dapat membentuk Cb48, Cb15 dan Cb42, hal ini 
menunjukkan bahwa cara tersebut berguna untuk memproduksi dan memurnikan antigen protein dalam jumlah besar untuk 
keperluan uji vaksin dan karakterisasi protein. 
Kata kunci: Chrysomya, membran peritrofik, peritrofin, protein rekombinan, hexaHis tag, GST 
ABSTRACT 
WIJFFELS, GENE., TONY VUOCOLO, SRI MUHARSINI, and FLORENTINA SUPRIYANTI. 2000. Bacterial expression of larval 
peritrophins of Chryosomya bezziana. Jurnal Ilmu Ternak dan Veteriner (Edisi Khusus) 5 (3): 170-176. 
Three candidate antigens, Chrysomya bezziana peritrophin-48, Chrysomya bezziana peritrophin-15 and Chrysomya bezziana 
peritrophin-42, were prepared for recombinant protein production in Escherichia coli using a variety of expression vectors. Cb 
peritrophin-48 was expressed as a recombinant protein possessing a carboxy-terminal hexaHis tag. Cb peritrophin-15 was 
expressed as both a glutathione S-transferase fusion protein and as an amino-terminal hexaHis tagged protein. The glutathione S-
transferase Cb peritrophin-15 construct produced a heterogeneous group of fusion proteins. Cb peritrophin-42 was also 
expressed as an amino-terminal hexaHis tagged protein. The two putative domains of Cb peritrophin-42 were also separately 
expressed, again with amino-terminal hexaHis tags. Cultures of the hexaHis constructs Cb peritrophin-48, -15 and –42 were 
demonstrated to be useful for the production and purification of these protein antigens and were scaled-up for vaccine trials and 
protein characterization studies. 
Key words: Chrysomya, peritrophic membrane, peritrophin, recombinant protein, hexaHis tag, GST 
INTRODUCTION 
Previous studies in another myiasis fly, Lucilia 
cuprina, have shown that intrinsic peritrophic 
membrane proteins (termed peritrophins) are potential 
vaccine antigens against the invasive larval stage. Three 
antigens, Chrysomya bezziana peritrophin-48, C. 
bezziana peritrophin-15 and C. bezziana peritrophin–42 
(abbreviated to Cb48, Cb15 and Cb42) were identified 
as peritrophins of the larval stage of the Old World 
Screwworm fly, C. bezziana (RIDING et al., 2000; 
VUOCOLO et al., 2000b). All three candidate antigens 
were successfully cloned from a C. bezziana larval 
cDNA library (VUOCOLO et al., 2000b). We set out to 
find means of expressing these three candidate vaccine 
antigens in Escherichia coli, in order to generate 
suitable quantities of the proteins for further studies. 
Development of any subunit vaccine requires access 
to reasonable quantities of pure antigen. It can be a 
difficult task producing sufficient quantities of pure 
native antigen to conduct all the protein characterization 
and vaccine trials required in the development of a 
vaccine and the native antigen will rarely be available 
in commercial quantities. This problem can usually be 
overcome by developing a recombinant vaccine 
typically using a bacterial and/or yeast protein 
expression system. This approach requires cloning of 
the gene encoding the candidate antigen into suitable 
expression vectors. Typically DNA is resynthesized by 
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PCR to have compatible ends (usually restriction 
enzyme sites) to allow ligation into a vector. 
Expression vectors are characterized by the presence 
of a strong inducible promoter to drive the transcription 
of the gene, and thus lead to good expression of the 
candidate antigen. Many expression vectors will 
generate a fusion protein with the antigen protein. The 
fused protein will contain either a peptide or protein 
that will assist with the identification and purification of 
the recombinant protein. Ideally, the introduced 
component should not interfere with the folding, 
antigenicity or behavior of the candidate vaccine 
protein. However, it is not uncommon for recombinant 
proteins to be produced as insoluble aggregates within 
cells. Processing of these aggregates into a form 
suitable for vaccination trials is the subject of another 
publication in this issue (PEARSON et al., 2000). 
MATERIALS AND METHODS 
Preparation and manipulation of DNA 
Oligonucleotide primers were designed to 
incorporate restriction enzyme cleavage sites (linkers) 
at their ends to allow cloning into expression vectors. 
The primers were synthesized on an Oligo 1000 DNA 
Synthesizer (Beckman Instruments), and then cleaved 
from the resin as instructed by the manufacturer. The 
cleaved oligonucleotides were dried by vacuum 
centrifugation (Savant), and then resolubilized in sterile 
water or a Tris-EDTA buffer. PCR was conducted in 50 
or 100 µl volumes using Taq polymerase and buffers 
from Promega and 100 pmol oligonucleotide primers 
(in an Omnigene Temperature Cycler (Hybaid)). PCR 
products were isolated from agarose gels and purified 
using DNA clean up kits (Bresaclean (Geneworks, 
Adelaide, Australia) and Qiagen (Germany). 
Purification was monitored by agarose gel 
electrophoresis run in TAE buffer (0.04M Tris-acetate, 
1mM EDTA). 
Vectors used in this work were pGEM-T and 
pGEM-T Easy (Promega, USA) for the cloning of PCR 
products. Vectors used for recombinant protein 
expression were pQE9 and pQE60 (Qiagen) and pGEX-
2T (Amrad-Pharmacia, Australia). These expression 
vectors are inducible with IPTG. All restriction 
enzymes used were obtained from Promega. DNA of 
the cloned PCR fragments were digested with 
restriction enzymes corresponding to their restriction 
linkers and gel purified. The expression vectors were 
cleaved at their cloning sites with the same restriction 
enzymes, phosphorylated with Calf Intestinal 
Phosphatase (Promega), and gel purified. The purified 
DNA fragments were ligated into the appropriately 
digested and purified expression vector with T4 DNA 
ligase (Promega). pGEM-T Easy recombinant plasmids 
were transformed into competent XL1-Blue cells. 
Recombinant expression vectors were transformed into 
competent XL1-Blue or M15 E. coli cells 
Expression trials 
Cultures of 3 ml Luria Bertani (LB) broth (1% w/v 
bacto-tryptone, 0.5% w/v bacto-yeast extract, 0.5% w/v 
NaCl, pH 7.5) containing 200 µg/ml ampicillin were 
inoculated from DMSO stocks of the expression clones 
and grown overnight (37°C) with shaking (250 rpm). 
The cultures were then added to 20 ml of prewarmed 
Superbroth (2.5% w/v bacto-tryptone, 1.5% w/v bacto-
yeast extract, 0.5% w/v NaCl, pH 7.5) containing 200 
µg/ml ampicillin and grown at 37°C with shaking (250 
rpm). When the OD600 reached 0.8, IPTG was added to 
a final concentration of 1 or 2 mM. Samples (1 ml) 
were taken at the time of induction and then at hourly 
intervals for 5 h. After determining the optical density 
at 600 nm (OD600), the samples were immediately 
pelleted (12000 g, 5 min, 4°C) and all supernatants 
removed. Pellets were stored at –20°C prior to analysis. 
On thawing, the pellets were resuspended in 2x 
reducing SDS-PAGE sample buffer at a theoretical 
density of OD600 = 10. The suspension was vortexed, 
heated to 100°C for 5 min and vortexed again. The 
homogenates were spun (12000 g, 2 min) to remove any 
insoluble material before loading on SDS-PAGE. 
Large scale expression experiments 
In preparation for 1-4 L broth cultures, 2 to 4 flasks 
of 100 ml Superbroth containing 200 µg/ml ampicillin 
were inoculated with 10 µl DMSO stock of the relevant 
plasmid in XL1-Blue or M15 cells. After overnight 
culture (37°C) on a shaker (250 rpm), an appropriate 
volume from each 100 ml culture was added to a 900 
ml volume of prewarmed Superbroth containing 200 
µg/ml ampicillin (in a 2 L flask) to give a starting OD600 
of 0.2. The 1 L broth cultures were mounted on a shaker 
and OD600 monitored. When the OD600 reached 0.6–0.8, 
IPTG was added to a final concentration of 1 or 2 mM. 
To monitor bacterial growth and induction of protein 
expression, 1.5 ml samples of the culture were removed 
at hourly intervals. After the final time point, the cells 
were pelleted (1500 g, 20 min, 4°C) and the supernatant 
removed. The pelleted cells were resuspended in cold 
TBS and transferred to 50 ml centrifuge tubes. The cells 
were washed twice in cold TBS containing EDTA-free 
CompleteTM protease inhibitors (Boehringer Mannheim, 
Germany) prior to being stored at –20°C. 
SDS-PAGE and Immuno-blots 
Minigels were prepared and run using the Bio-Rad 
(USA) Minigel systems. Midi-gradient gels (6–18% 
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acrylamide) were assembled and run with a Bio-Rad 
system. All gels were run under reducing conditions. 
Gels were either stained with Coomassie Brilliant Blue 
or silver stained (RABILLOUD et al., 1988), and 
occasionally electro-transfered for immuno-blot 
analysis (as described by WIJFFELS et al., 1996 for 
minigels, and EAST et al., 1993 for midi-gels). 
Immuno-blot analyses employed various probes to 
identify the recombinant proteins. The hexaHis tag 
produced as a consequence of expression in the Qiagen 
vectors was detected by two means: a Ni-NTA alkaline 
phosphatase conjugate (Qiagen) and specific antibody 
reagents. An affinity purified anti-hexaHis reagent was 
prepared by passing a 100 ml pool of sheep sera raised 
against a hexaHis tagged version of L. cuprina 
peritrophin-48 (SCHORDERET et al., 1998) down a 
Sepharose column conjugated with a H. irritians exigua 
aquaporin possessing an amino-terminal hexaHis tag 
(ELVIN et al., 1999). The eluted antibodies were 
specific for the hexaHis tag and the four preceding 
residues Met-Arg-Gly-Ser. An affinity purified reagent 
to GST was prepared in a similar manner. A pool of 
sheep sera against L. cuprina peritrophin-44 fused to 
GST was passed down a GST-Sepharose column. The 
eluted antibodies were specific for GST. 
If possible, serum raised to the antigen was also 
used. In the case of hexaHis-Cb15, a pool of sheep 
serum to the Cb-peritrophic membrane (PM) SDS 
extract, which was highly enriched for Cb15, was 
prepared. Six sheep were immunized subcutaneously 
with 3 mg Cb PM SDS extract. The protein extract was 
emulsified in the adjuvant, Montanide ISA70 (Seppic, 
Paris, France) with a hand held motorized pestle 
(Kontes, Vineland, NJ). The sheep received two 
subcutaneous injections, 4 weeks apart in the right hind 
leg. Two weeks after the final immunization, blood was 
collected by venepuncture. The sera were stored at –
20°C until required. The pooled sera were absorbed 
against a lysate of E. coli expressing L. cuprina 
hexaHis-PM55 to ensure that the pooled sera did not 
possess specificities to E. coli proteins that would 
confound immuno-blot analyses of lysates. The sera 
were analyzed to determine which sera reacted to Cb15 
by immuno-blot analyses. The 3 most reactive sera 
were pooled (1.5 ml each). A pool was also prepared 
from the corresponding pre-vaccination sera. Bacterial 
lysate (3.5 ml) was added to both pools, and the 
mixtures were rotated for 2 h (4°C) and then clarified 
(10000 g, 15 min, 4°C). The supernatants were further 
absorbed against the E. coli with another 2 ml lysate 
overnight with rotation (4°C). The mixtures were 
clarified again before addition of a further 1.5 ml lysate 
and absorption for another 2 h (4°C). The mixture was 
finally clarified (20000 g, 30 min, 4°C). The absorbed 
sera pools (now a 9.5 ml volume) were aliquoted and 
stored at –20°C. 
An affinity purified antibody reagent was also 
prepared for the detection of hexaHis-Cb42 and its 
domains. HexaHis-Cb42 produced from E. coli was 
purified as described (PEARSON et al., 2000). The 
protein was homogenized into Montanide ISA 70 
(Seppic) as described above. Two rabbits each received 
three subcutaneous immunizations of 30 µg hexaHis-
Cb42 over 12 weeks. Their sera were collected two 
weeks after the final boost. After verification of 
immunoreactivity by immuno-blot analysis and ELISA, 
the hexaHis-Cb42 specific antibodies were affinity 
purified. A Cb42–Sepharose conjugate was produced 
by conjugating 3 mg purified hexaHis-Cb42 to 1.5 g 
cyanogen bromide activated-Sepharose 4B (Pharmacia) 
according to the manufacturer’s instructions. The 
Cb42–Sepharose conjugate was poured into a glass 
column (Bio-Rad). The rabbit serum was dialyzed 
against 100 mM Tris, pH 8.0 containing 0.5 M NaCl 
(4°C). The serum was loaded onto the column, washed 
in the Tris buffer and the specifically bound antibodies 
eluted with 0.2 M glycine-HCl (pH 2.2). The eluant was 
neutralized by addition of saturated Tris and then was 
dialyzed against PBS pH 7.2 (4°C). The eluted antibody 
solution was concentrated using a Centricon 30 device 
(Millipore, Bedford, MA). 
RESULTS AND DISCUSSION 
Cloning and expression of Cb48 
A DNA fragment encoding the mature Cb48 protein 
sequence, 345 amino acids, was amplified by PCR 
using BamH I linkered primers as described in 
VUOCOLO et al. (2000a), purified and cloned into 
pQE60. This vector fuses a hexaHis tag to the carboxy-
terminus of the expressed recombinant protein. The 
recombinant plasmids were transformed into E. coli 
M15 cells. Twelve individual colonies were picked, 
plasmid DNA isolated and digested with BamH I to 
verify the presence of the Cb48 insert DNA. Pilot 
cultures of twelve Cb48 E. coli clones were assayed for 
recombinant protein expression. These clones were all 
shown to contain the expression plasmid and the Cb48 
DNA (Figure1, Panel A). Only clones 5, 7 and 12 were 
found to contain inserts in the correct orientation (data 
not shown). All 12 clones with insert and a vector only 
clone were used in pilot expression studies. SDS-PAGE 
run under reducing conditions and stained with 
Coomassie Blue, (Figure1, Panel B) shows the protein 
profile produced by these clones. No Cb48 recombinant 
protein was apparent from this gel. Immuno-blot 
analysis using a Ni-NTA conjugate was used to detect 
expression of recombinant Cb48 (Figure1, Panel C). 
Only clones in the correct orientation (5, 7 and 12) were 
expected to produce recombinant Cb48 protein. Indeed, 
it was shown that only clones 7 and 12 produced 
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recombinant Cb48 with no apparent expression in clone 
5. An unstained standard containing carbonic anhydrase 
(30 kDa) served as a positive control for the Ni-NTA 
conjugate. Carbonic anhydrase binds directly to the 
nickel conjugate. Clone 12 was DNA sequenced to 
verify that it accurately encoded Cb48. A 4 L culture of 
clone 12 was grown and recombinant Cb48 protein was 
found to be present in the form of inclusion bodies in 
the E. coli cells. These inclusion bodies were 
solubilized and purified as outlined by PEARSON et al. 
(2000). 
 
Figure 1. Analysis of twelve Cb48 recombinant 
bacterial clones for expression of hexaHis-
Cb48. Lanes 1 to 12, Cb48 recombinant 
clones; lane S, DNA standards; lane *, 
pQE60 vector only (control). Panel A: 1% 
agarose gel with clones digested with BamH 
I. Panel B: Coomassie Blue stained SDS-
PAGE gel of pilot expression cultures run 
under reducing conditions. Panel C: Immuno-
blot analysis of expression cultures probed 
with a Ni-NTA alkaline phosphatase 
conjugate. Unstained carbonic anhydrase was 
a positive reaction control for the Ni-NTA 
conjugate reaction in lane CA 
Cloning and expression of Cb15 
The DNA encoding Cb15 was cloned into the 
expression vectors pQE9 and pGEX-2T. The pQE9 
vector will yield a recombinant protein with an amino-
terminal hexaHis tag, whereas the pGEX-2T vector will 
produce a fusion protein with an amino-terminal GST 
domain. To simplify preparation, the inserts and vectors 
were prepared for bi-directional cloning. pQE9 and 
pGEX-2T were digested with Hind III and EcoR I, 
respectively. Forward and reverse primers containing 
the Hind III and EcoR I restriction sites were prepared 
and used in a PCR to generate the inserts. The inserts 
were first cloned into pGEM-T, an intermediate vector 
and transformed into competent XL1-Blue cells. Inserts 
from pGEM-T vector were digested with Hind III and 
EcoR I and were ligated into the relevant expression 
vector. Only 7 pGEX-2T and a single pQE9 
transformant resulted. DNA sequencing demonstrated 
that each transformant contained the correct insert in the 
correct orientation. 
Pilot expression experiments of 2 pGEX-2T 
transformants and the pQE9 transformant were 
conducted in 20 ml cultures, with samples of the culture 
removed hourly for 5 h after induction with 2 mM 
IPTG. SDS-PAGE and immuno-blots were used to 
analyse the samples for Cb15 recombinant protein 
expression (data not shown). The hexaHis-Cb15 protein 
was just discernible in the Coomassie Blue stained gel, 
but clearly evident in a Western blot probed with a 
hexaHis antibody (Figure 2). The GST-Cb15 fusion 
protein was not detected in the Coomassie stained gel, 
but a 32–38 kDa band was detected in a Western blot 
probed with a GST antibody. Scale up to 2 L culture 
expression experiments were undertaken. 
As with the pilot expression experiments, the 2 L 
pGEX-2T culture was sampled hourly before and after 
induction. There were three forms of expressed protein: 
26, 32 and 38 kDa, evident in the Coomassie Blue 
stained gel and immuno-blot analysis using the anti-
GST serum. The expression pattern did not change in 
quantity or profile with time. The minor 26 kDa band is 
likely to be GST alone and the fusion proteins are 
probably represented by the two more slowly migrating 
forms. The predicted size of the Cb15 only polypeptide 
is 8 kDa. However native Cb15 protein has only been 
seen to migrate at 15 kDa in SDS-PAGE (RIDING et al., 
2000). The 38 kDa protein is therefore reasonably 
consistent with a GST-Cb15 protein comprising 26 kDa 
and 15 kDa for the GST and Cb15 component 
respectively. The 32 kDa protein may represent the 
product of a partial mRNA of the gene, or a GST-Cb15 
misfolded protein. 
Analysis of time points of the hexaHis-Cb15 2 L 
culture gave very clear results (Figure 3). The Cb15 
recombinant protein was evident in the Coomassie blue 
stained gel and both immuno-blot analyses. Extended 
growth after the 55 min time point (post-induction) did 
not improve the amount of the 15 kDa recombinant 
protein. 
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Figure 2. Analyses of the induction of GST-Cb15 expression in 2 L culture. Time point samples of a 2 L culture of a 
pGEX-2T transformant were analyzed for expression of GST-Cb15 by SDS-PAGE and immuno-blot analyses 
using the antibody to GST. Time points are as indicated. The 12% acrylamide gels were loaded as described in 
Material and Methods, and Coomassie stained or processed for immuno-blotting 
 
 
Figure 3. Analyses of the induction of hexaHis-Cb15 expression in 2 L culture. Time point samples of a 2 L culture of the 
pQE9 transformant were analyzed for expression of hexaHis-Cb15 by SDS-PAGE and immuno-blot analyses 
using an anti-hexaHis serum and an E. coli absorbed anti-Cb PM SDS extract. Time points are as indicated. The 
20% acrylamide gels were loaded as described in Material and Methods, and Coomassie stained or processed for 
immuno-blotting 
Cloning and expression of Cb42 and its two domains 
Recombinant expression of Cb42 was performed in 
the pQE9 expression vector. A sense primer containing 
a BamH I linker and an anti-sense primer containing a 
Hind III linker were prepared and successfully used in 
PCR on the K1.1 phagemid (VUOCOLO et al., 2000b). 
The 500 bp product was purified and ligated into 
pGEM-T Easy for sequencing. The verified fragment 
was then ligated into BamH I/Hind III cut and 
phosphatased pQE9. The ligated plasmid was 
transformed into competent XL1-Blue cells, and 3 
clones were picked and shown to possess the fragment 
encoding Cb42 (Figure 4, lane 1). Pilot expression trials 
were conducted on all three transformants. Two of the 
three clones expressed hexaHis-Cb42 and one clone 
was grown in a large scale (8 L) culture. HexaHis-Cb42 
was expressed after induction with 1 mM IPTG, but 
SDS-PAGE analysis of the cell lysate showed that the 
protein was insoluble in the form of inclusion bodies 
(Figure 5, lane 1). 
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Figure 4. Insert sizes of Cb42, Cb42A and Cb42B 
pQE9 clones. Purified pQE9 DNA of a full 
length Cb42 clone (lane 1), a domain A clone 
(lane 2) and a domain B clone (lane 2) were 
digested with BamH I and Hind III to release 
the inserts (as indicated by the arrows). Lanes 
L are DNA marker ladders (Gibco-BRL). The 
DNA products were resolved in a 1% agarose 
gel and stained with ethidium bromide 
 
Figure 5. Immuno-blot analysis of the expression trial of 
pQE9 constructs of full length hexaHis-Cb42, 
or hexaHis tagged Cb42 domain A or B. The 
insoluble cellular material of a bacterial cell 
lysate of cells induced with 1 mM IPTG, was 
solubilized in SDS-PAGE reducing sample 
buffer. The solubilized pellet was analyzed for 
the presence of the recombinant protein by 
immuno-blot analysis using the Ni-NTA 
alkaline phosphatase conjugate. Lane 1, 10 µl 
full length Cb42 solubilized pellet; lanes 2 and 
3, 10 and 20 µl domain A solubilized pellet 
respectively, and lanes 4 and 5, 10 and 20 µl 
domain B solubilized pellet respectively 
A soluble recombinant protein is generally more 
useful in vaccine trial work and is essential for protein 
function and characterization studies. In the hope of 
generating soluble protein, the Cb42 protein was 
divided into 2 recognizable domains implied from its 
primary sequence. Domains A and B each represent 
approximately one half of Cb42. Domain B has 
sequence similarities to Cb15. The same method used in 
constructing the full length Cb42 expression plasmid 
was applied to assembling the domain A and B 
constructs. Each construct was engineered to contain an 
amino-terminal hexaHis tag. The PCR fragments 
containing BamH I/Hind III restriction sites at their 
ends were 200 and 220 bp for Cb42 domain A and B 
respectively. These fragments were directionally cloned 
into pQE9 expression vector cut with BamH I and Hind 
III after shuttling through pGEM-T Easy vector. 
Transformants in XL1-Blue cells containing the correct 
fragment are shown in Figure 4 (lanes 2 and 3). The 
DNA from 2 clones for each construct was sequenced 
and found to be correct. One of each of these clones 
was taken on to pilot expression trials. Both constructs 
produced insoluble proteins of approximately 14 kDa, 
although the domain B construct appeared to be 
expressing at very low levels (Figure 5, lanes 2 - 5). In a 
larger volume culture (750 ml) induced with 1 mM 
IPTG, both constructs produced similar amounts of 
insoluble recombinant protein (data not shown). 
CONCLUSION 
The results of the attempted expression of five 
different recombinant antigens in three different 
expression vectors are summarized in Table 1. Clearly, 
all five antigens, representing all or part of three 
candidate native antigens, were produced in reasonable 
quantity as recombinant proteins in E. coli. 
Nevertheless, the results also show the variability of the 
ease with which expression is achieved in different 
protein/vector combinations, despite the fact that the 
three antigens of interest have a number of structural 
similarities. This demonstrates the need to adopt a 
flexible approach to the expression of any protein 
needed in quantity and good purity for further 
biochemical or veterinary research. 
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Table 1. Summary of bacterial expression constructs engineered for recombinant protein production of Cb15, Cb42 and 
Cb48 
Protein Expression Vector Intended Recombinant Protein Result 
Cb15 pQE9 N-terminus hexaHis tagged Cb15. Successful expression of a single soluble product. 
High yields. 
 pGEX-2T N-terminus GST fused Cb15. Successful expression/multiple soluble products 
obtained. 
Cb42 pQE9 N-terminus hexaHis tagged Cb42. Successful expression of a single product. High 
yields. Insoluble product. 
Cb42A 
(Domain A) 
pQE9 N-terminus hexaHis tagged Cb42 
Domain A.  
Successful expression of a single product. High 
yields. Insoluble product. 
Cb42B 
(Domain B) 
pQE9 N-terminus hexaHis tagged Cb42 
Domain B. 
Successful expression of a single product. Low 
yields. Insoluble product. 
Cb48 pQE60 C-terminus hexaHis tagged Cb48. Successful expression of a single product. 
Satisfactory yields. Insoluble product. 
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